AmerisourceBergen/Xcenda Policy Experts Discuss Biosimilar Strategy

Center for Biosimilars, Tasmina Hydery and Jennifer Snow

In this interview, Center for Biosimilars® Senior Editor Tony Hagen discusses formulary decisions and drug price reform with AmerisourceBergen/Xcenda drug reimbursement experts Jennifer Snow, MPH, vice president of Reimbursement and Policy Insights, and Tasmina Hydery, PharmD, MBA, BCGP, assistant director of Integrated Technology Solutions.

Both Snow and Hydery discussed pharmacy and biosimilars in a panel discussion at the recent Academy of Managed Care Pharmacy Nexus 2021 meeting.

To watch the full interview, visit Center for Biosimilars.